Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-α Activation in Obese Subjects Post Bariatric Surgery
Overview
Authors
Affiliations
Bariatric surger (BS) is characterized by lipid metabolic changes as a response to the massive release of non-esterified fatty acids (NEFA) from adipose depots. The study aimed at evaluating changes in polyunsaturated fatty acids (PUFA) metabolism and biosynthesis of the lipid mediators -acylethanolamines (NAE), as indices of nuclear peroxisome proliferator-activated receptor (PPAR)-α activation. The observational study was performed on 35 subjects (27 female, 8 male) with obesity, undergoing bariatric surgery. We assessed plasma FA and NAE profiles by LC-MS/MS, clinical parameters and anthropometric measures before and 1 and 6 months after bariatric surgery. One month after bariatric surgery, as body weight and clinical parameters improved significantly, we found higher plasma levels of -oleoylethanolamine, arachidonic and a 22:6-n3/20:5-n3 ratio as evidence of PPAR-α activation. These changes corresponded to higher circulating levels of NEFA and a steep reduction of the fat mass. After 6 months 22:6-n3/20:5-n3 remained elevated and fat mass was further reduced. Our data suggest that the massive release of NEFA from adipose tissue at 1-Post, possibly by inducing PPAR-α, may enhance FA metabolism contributing to fat depot reduction and improved metabolic parameters in the early stage. However, PUFA metabolic changes favor n6 PUFA biosynthesis, requiring a nutritional strategy aimed at reducing the n6/n3 PUFA ratio.
Patt M, Karkossa I, Krieg L, Massier L, Makki K, Tabei S EBioMedicine. 2024; 110:105458.
PMID: 39608059 PMC: 11638646. DOI: 10.1016/j.ebiom.2024.105458.
Research progress on bariatric surgery for hyperuricemia.
Song K, Kong X, Yu Z, Xiao H, Ren Y BMC Surg. 2024; 24(1):235.
PMID: 39169366 PMC: 11337558. DOI: 10.1186/s12893-024-02525-w.
Takahashi N, Sasaki A, Umemura A, Sugai T, Kakisaka K, Ishigaki Y Biomedicines. 2022; 10(11).
PMID: 36428489 PMC: 9687903. DOI: 10.3390/biomedicines10112920.